Clinical significance of serum fibroblast growth factor 23 as a surrogate marker of the cardiorenal hemodynamic state in patients with heart failure

被引：0
|
作者：
Imazu, M. [1 ]
Takahama, H. [1 ]
Asanuma, H. [2 ]
Funada, A. [1 ]
Ohara, T. [1 ]
Hasegawa, T. [1 ]
Asakura, M. [1 ]
Kanzaki, H. [1 ]
Anzai, T. [1 ]
Kitakaze, M. [1 ]
机构：
[1] Natl Cerebral & Cardiovasc Ctr Hosp, Dept Cardiovasc Med, Suita, Osaka, Japan
[2] Kyoto Prefectural Univ Med, Kyoto, Japan
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：781 / 782
页数：2
相关论文
共 50 条
  • [1] Fibroblast growth factor 23 and heart failure: the plot thickens
    Gutierrez, Orlando M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (05) : 688 - 690
  • [2] FIBROBLAST GROWTH FACTOR 23 IS A NOVEL BIOMARKER FOR CARDIAC FUNCTION IN HEART FAILURE PATIENTS
    Imazu, Miki
    Asakura, Masanori
    Takahama, Hiroyuki
    Nakano, Atsushi
    Funada, Akira
    Sugano, Yasuo
    Ohara, Takahiro
    Hasegawa, Takuya
    Kanzaki, Hideaki
    Anzai, Toshihisa
    Asanuma, Hiroshi
    Kitakaze, Masafumi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A795 - A795
  • [3] THE ASSOCIATION OF FIBROBLAST GROWTH FACTOR-23 AND CARDIORENAL SYNDROME IN PATIENTS WITH DIABETES MELLITUS
    Vasilkova, Volha
    Pchelin, Ivan
    Mokhort, Tatiana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I621 - I621
  • [4] FIBROBLAST GROWTH FACTOR 23 AND HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Ghuman, Jasleen
    Cai, Xuan
    Hecktman, Jonathan
    Shah, Sanjiv
    Wolf, Myles
    Isakova, Tamara
    Mehta, Rupal
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 675 - 675
  • [5] Fibroblast growth factor-23 is associated with disease severity in patients with stable heart failure
    Trenkler, C.
    Kliebhan, J.
    Ess, M.
    Wuertinger, P.
    Griesmacher, A.
    Kaser, S.
    Frick, M.
    Poelzl, G.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S64 - S65
  • [6] Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure
    Anne Cornelissen
    Roberta Florescu
    Kinan Kneizeh
    Christian Cornelissen
    Vincent Brandenburg
    Elisa Liehn
    Alexander Schuh
    Scientific Reports, 11
  • [7] Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure
    Cornelissen, Anne
    Florescu, Roberta
    Kneizeh, Kinan
    Cornelissen, Christian
    Brandenburg, Vincent
    Liehn, Elisa
    Schuh, Alexander
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Fibroblast growth factor-23 is associated with disease severity in patients with stable heart failure
    Trenkler, C.
    Kliebhan, J.
    Ess, M.
    Wuertinger, P.
    Griesmacher, A.
    Kaser, S.
    Frick, M.
    Poelzl, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S164 - S164
  • [9] Assessment of intact fibroblast growth factor 23 in patients with heart failure with reduced ejection fraction
    Gruson, D. Damien
    Ahn, S.
    Ferracin, B.
    Rousseau, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 290 - 290
  • [10] Fibroblast growth factor-23 is associated with disease severity in patients with stable heart failure
    Trenkler, C.
    Kliebhan, J.
    Ess, M.
    Wuertinger, P.
    Griesmacher, A.
    Frick, M.
    Poelzl, G.
    EUROPEAN HEART JOURNAL, 2013, 34 : 776 - 776
12345